Biotechnology: Strategic Intelligence
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Biotechnology leverages biological processes to develop technologies and products for specific applications across healthcare, agriculture, and industrial sectors. In healthcare, biotechnology drives the production of therapeutic proteins and advanced drugs. In agriculture, it enhances crop yields, pest resistance, and nutritional value, supporting sustainable farming practices. In industrials, biotech harnesses enzymes and microorganisms to create bio-based materials, including fuels, plastics, and other sustainable solutions.
Scope
This report provides a comprehensive overview of the biotechnology theme, covering the entire value chain across six layers:
Research & Discovery
Preclinical & Clinical Development
Manufacturing & Bioprocessing
Commercialization & Market Access
End Markets
Funding & Investment
The report also explores how biotechnology is reshaping healthcare, agriculture, and industrial sectors, highlighting the technologies, strategies, and innovations driving industry transformation.
How industry leaders are using this report
Biotech leaders and stakeholders leverage this report to:
Identify high-value applications of biotechnology across healthcare, agriculture, and industrial sectors.
Benchmark competitors and innovators, spotting emerging players and technologies to watch.
Guide R&D and investment strategy, prioritizing opportunities with strong commercial potential.
Understand regulatory and funding landscapes, aligning business strategies with global trends.
Optimize value chains from research and development to commercialization, maximizing ROI and market impact.
Key Highlights
Artificial intelligence (AI), cloud computing, and data analytics help the analysis of complex biological data, which advances what biotech can achieve. For example, machine learning can look at complex data sets and identify potential patterns and predict biological functions.
Gene editing tools like CRISPR enable precise modification of DNA. These technologies are revolutionary. For example, they can treat genetic diseases and create disease-resistant crops.
Synthetic biology can create new biological systems that enable the construction of new products like biofuels or therapeutics.
Reasons to Buy
Biotechnology has the potential to transform major industries. This report provides an invaluable overview of this disruptive theme, including analysis of the leading companies and a detailed discussion of use cases across industries. The report further enables you to:
Gain a strategic understanding of biotechnology and its transformative potential across multiple industries.
Access analysis of leading biotech companies and emerging technologies shaping the sector.
Explore real-world use cases and applications in healthcare, agriculture, and industrials.
Stay informed about trends, innovations, and funding priorities critical to growth and investment decisions.
Who should buy this report
- Biotechnology and Life Sciences Companies
- Pharmaceutical and Healthcare Organizations
- Agriculture and AgriTech Firms
- Industrial and Bio-based Materials Companies
- Investors, Venture Capital, and Private Equity Firms
- R&D, Innovation, and Strategy Teams
- Consultants and Strategic Advisors
Agilent Technologies
Amgen
Angeles Therapeutics
ARCH Venture Partners
Astra Zeneca
ATCC
BASF
Bayer
Beam Therapeutics
Becton Dickinson
BeiGene
BenevolentAI
Biocon
BioMason
Bionema
Biontech
Boehringer Ingelheim
BPS Bioscience
Brandon Bioscience
Bristol Myers Squibb
Cadence
Carbios
Caribou Biosciences
Catalent
Cell Biolabs
Celltrion
CG Oncology
Charles River Laboratories
Chemical Computing Group
Codexis
Coherus
Corteva Agriscience
CRISPR Therapeutics
CSL Behring
Cyagen
Cyrus Biotechnology
Cytiva
Daiichi-Sankyo
Deep Genomics
Dendreon
DNAnexus
Editas Medicine
Element Biosciences
Elo Life Systems
Eurofins
Evotec
Fera Science Limited
Ferring Pharmaceuticals
Flagship Pioneering
Fortera
Fortrea
Foundation Medicine
Fujifilm Diosynth Biotechnologies
Genedata
Genelux
Genomatica
GenScript
Gilead Biosciences
Ginkgo Bioworks
Groundwork BioAg
Hengrui
HutanBio
ICON
Illumina
Inari
Insilico Medicine
Intellia Therapeutics
IQVIA
Johnson & Johnson
Justin Stindt Consultants
Keel Labs
Kintiga
Kula Bio
LanzaTech
LFB Biomanufacturing
Lonza
Lululemon
MaaT Pharma
Medpace
Merck
MilliporeSigma
Moderna
Molsoft
Mtech Access
MYCOworks
Myriad Genetics
NatureWorks
Net Zero Nitrogen
New England Biolabs
Novartis
Novozymes
Oncolytics Biotech
Optibrium
Orbimed
PacBio
Pairwise
Parexel
Pfizer
Pharmaron
Prime Medicine
Promega
Qiagen
Razbio
Recipharm
Recursion
Regeneron
Rentschler Biopharma
Replimune
RJW&Partners
Roche
Rubi Laboratories
Samsung Biologics
Samusung Bioepis
Sandoz
Sanofi
Sartorius
Schrődinger
Selexis
Sentieon
Seres Therapeutics
Shenzen SiBiono GeneTech
Siegfried Holding
SimulationsPlus
Sirona Dx
Sofinnova partners
Sophia Genetics
Spiber
Sugarox
Sunway
Syneos Health
Syngenta
TFS HealthScience
Thermo Fisher Scientific
Third Rock Ventures
Transgene
Tropic
Twist Bioscience
UDG Healthcare
Ultima Genomics
UPL
Versant Ventures
Vintura
WuXi Biologics
WuXia
XtalPi
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Technology reports